DE69633681D1 - Verfahren zur feststellung von reperfusion nach thrombolytischer therapie - Google Patents

Verfahren zur feststellung von reperfusion nach thrombolytischer therapie

Info

Publication number
DE69633681D1
DE69633681D1 DE69633681T DE69633681T DE69633681D1 DE 69633681 D1 DE69633681 D1 DE 69633681D1 DE 69633681 T DE69633681 T DE 69633681T DE 69633681 T DE69633681 T DE 69633681T DE 69633681 D1 DE69633681 D1 DE 69633681D1
Authority
DE
Germany
Prior art keywords
thrombolytic therapy
onset
patient
variable
predetermined time
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69633681T
Other languages
English (en)
Other versions
DE69633681T2 (de
Inventor
Magnus Ohman
H Christenson
M Califf
Mary Ann O'hanesian
N Sigmon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Durham
Duke University
Original Assignee
University of Durham
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Durham, Duke University filed Critical University of Durham
Application granted granted Critical
Publication of DE69633681D1 publication Critical patent/DE69633681D1/de
Publication of DE69633681T2 publication Critical patent/DE69633681T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/50—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving creatine phosphokinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
DE69633681T 1995-08-17 1996-08-16 Verfahren zur feststellung von reperfusion nach thrombolytischer therapie Expired - Fee Related DE69633681T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51615995A 1995-08-17 1995-08-17
US516159 1995-08-17
PCT/US1996/013264 WO1997006725A1 (en) 1995-08-17 1996-08-16 Method of assessing reperfusion after thrombolytic therapy

Publications (2)

Publication Number Publication Date
DE69633681D1 true DE69633681D1 (de) 2004-11-25
DE69633681T2 DE69633681T2 (de) 2005-11-17

Family

ID=24054387

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69633681T Expired - Fee Related DE69633681T2 (de) 1995-08-17 1996-08-16 Verfahren zur feststellung von reperfusion nach thrombolytischer therapie

Country Status (6)

Country Link
US (1) US6033364A (de)
EP (1) EP0869733B1 (de)
AT (1) ATE279876T1 (de)
AU (1) AU6775996A (de)
DE (1) DE69633681T2 (de)
WO (1) WO1997006725A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6662114B1 (en) 1999-08-23 2003-12-09 Duke University Methods for evaluating therapies and predicting clinical outcome related to coronary conditions
US7074194B2 (en) * 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
US20060253300A1 (en) * 2005-05-03 2006-11-09 Somberg Benjamin L System and method for managing patient triage in an automated patient management system
SE532103C2 (sv) 2006-12-12 2009-10-27 Knut Johansen Metod för att bestämma hälsostatus från analyter i vätskeprover
US20090292213A1 (en) * 2008-05-21 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US8636670B2 (en) * 2008-05-13 2014-01-28 The Invention Science Fund I, Llc Circulatory monitoring systems and methods
US20100036263A1 (en) * 2008-08-07 2010-02-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090287120A1 (en) 2007-12-18 2009-11-19 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US9717896B2 (en) 2007-12-18 2017-08-01 Gearbox, Llc Treatment indications informed by a priori implant information
US20090292214A1 (en) * 2008-05-22 2009-11-26 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Circulatory monitoring systems and methods
US20090163856A1 (en) * 2007-12-19 2009-06-25 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Treatment indications informed by a prior implant information

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2027434C (en) * 1990-10-12 1999-01-05 George Jackowski Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof
US5246001A (en) * 1992-03-31 1993-09-21 Duke University Method of assessing reperfusion after thrombolytic therapy

Also Published As

Publication number Publication date
EP0869733A1 (de) 1998-10-14
WO1997006725A1 (en) 1997-02-27
DE69633681T2 (de) 2005-11-17
ATE279876T1 (de) 2004-11-15
AU6775996A (en) 1997-03-12
EP0869733B1 (de) 2004-10-20
EP0869733A4 (de) 1998-10-14
US6033364A (en) 2000-03-07

Similar Documents

Publication Publication Date Title
ATE279876T1 (de) Verfahren zur feststellung von reperfusion nach thrombolytischer therapie
DE68921948D1 (de) System und Verfahren zur Erkennung und Behandlung von ventrikulären Arrhythmien.
DE69720274D1 (de) Anzeige des auftretens von herzschlägen
DE69130289T2 (de) Therapeutische verwendung von actin-bindenden verbindungen
DE3869490D1 (de) Verfahren zur elektrochemischen behandlung von stoffen.
ATE268477T1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
EP1361229A3 (de) Verwendung von Tyrosine Kinase (PYK2) zur Produktion von Antikörper
DE69510336D1 (de) Verfahren zur diagnose von praeklampsie
DE3888205D1 (de) Verfahren zur behandlung von lungenaffektionen und zubereitungen dafür.
NO920125D0 (no) Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fri protein s eller protein c i en plasma-proeve
DE68928728T2 (de) Diagnose von retinoblastoma
Apple et al. Analyses of creatine kinase isoenzymes and isoforms in serum to detect reperfusion after acute myocardial infarction.
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
Selmayr et al. Chromatography and electron microscopy of cross‐linked fibrin polymers—a new model describing the cross‐linking at the DD‐trans contact of the fibrin molecules
ATE323176T1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
Ouyang et al. The effects of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on blood coagulation in vivo
DE69734890D1 (de) Rdgb-proteine
DE69719978D1 (de) Screening von wirkstoffen zur behandlung von alzheimer-krankheit
ATE148233T1 (de) Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern
Höfeler et al. Fibronectin and factor VIII-related antigen in liver cirrhosis and acute liver failure
SU1711083A1 (ru) Способ оценки эффективности лечени больных системной красной волчанкой
Al-Mondhiry et al. Platelet release in coronary heart disease: Effect of antiplatelet drugs and coronary artery bypass graft
Smith et al. The origins of adaptation in the auditory nerve
SU1714510A1 (ru) Способ определени гормональной зависимости при аутоиммунных заболевани х

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee